医学
不利影响
介绍
多学科方法
重症监护医学
癌症
多学科团队
癌症治疗
儿科
医疗急救
肿瘤科
内科学
家庭医学
护理部
社会科学
社会学
作者
Elia Seguí,Carles Zamora,Tanny Daniela Barreto,Joan Padrosa,Margarita Viladot,Javier Marco‐Hernández
出处
期刊:Diagnostics
[Multidisciplinary Digital Publishing Institute]
日期:2022-08-31
卷期号:12 (9): 2116-2116
被引量:9
标识
DOI:10.3390/diagnostics12092116
摘要
Immune checkpoint inhibitors (ICI) have revolutionized the landscape of cancer treatment. Although several studies have shown that ICIs have a better safety profile than chemotherapy, some patients develop immune-related adverse events (irAEs), which require specialized and multidisciplinary management. Since ICI indications are rapidly increasing, it is crucial that clinicians involved in cancer care learn to identify irAEs and manage them properly. Here, we report a case series of 23 patients with severe irAEs requiring hospitalization over a period of 12 months and seize the opportunity to review and update different general features related to irAEs along with the management of the most frequent severe irAEs in our series.
科研通智能强力驱动
Strongly Powered by AbleSci AI